Digital Transformation of Pharma Value Chain with Advanced Analytics
Pharma & life sciences is undergoing rapid transformation
Per McKinsey, several pharma companies have already made significant investments (~$300-400 Mn) in people, platform, project and data with a large portfolio of analytics experiments, establishing analytics COEs. Leveraging data and analytics present a real opportunity to scale for these pharma companies.
This is fueled by the five forces at play
Increasing healthcare cost pressures
Increasing patient centricity & personalization
Entry of digital natives into healthcare
Transforming the role of healthcare stakeholders
Tech advances in data science, analytics, etc
We are the trusted data science
partners for pharma Companies
How our Solutions transform the pharma value chain?
Gramener offers deep pharmaceutical domain expertise on the industry’s challenges & data needs across R&D, Pharma Operations, and Sales & Marketing functions.
We start every project with a ‘data advisory to implementation’ approach. This is followed by creating a data & analytics roadmap and partnering seamlessly with the best of breed 3rd party software and service providers already chosen by clients to ensure optimal business impact.
Coupled with our ‘business first, technology later’ approach, we assess the business impact potential for the client by implementing a use-case and investigating if there is a positive ROI potential upfront.
We bring to the table customized analytics solutions, actionable insights, a strong knowledge of regulatory compliances with an emphasis on data security and privacy and a long-term partnership with client focused on continuous monitoring and improvement.
Gramener’s data & AI offerings for
pharma & life sciences
Drug Research & Development
Computer vision & NLP-based AI offerings for drug content analytics, automated cell counting, anonymizing patient data, generating clinical study reports and developing patient narratives
Pharma
Operations
To support pharma operations optimally, Gramener can create a digital twin of your pharma operations process in order to optimize the yield from drug manufacturing as well as to improve the Overall Equipment Effectiveness (OEE)
Pharma Sales & Marketing
Leveraging pharma analytics such as physician segmentation, performance data, trade network, and historic calling patterns to offer personalization at scale through sales incentives, communication strategies and more
Some of Our Many Successful Use Cases
Elevate your commercial pharma strategies with our Gen AI solutions, designed exclusively for decision-makers.
Engage healthcare professionals profoundly through our Creative Image Generation tool, tailoring visuals precisely.
Boost your team’s expertise subtly with our Smart Sales Training Solution, accommodating individual learning styles. Experience streamlined processes and enhanced engagements without overwhelming complexities. Join us in this transformative journey, where innovation meets practicality, empowering your commercial pharma endeavors effortlessly.
The AI platform for clinical trial report submission is here. Our solution will simplify and streamline the clinical trial report submission process, ensuring compliance with complex data privacy regulations. It’s UI/UX-led approach using customized algorithms takes the pain out of complex regulatory compliance. It offers:
- Cutting edge AI
- User-centered Design, and
- Expert Regulatory Compliance Algorithms
- Simplification of compliance with the evolving stringent global regulatory disclosure & submission rules.
For one of our clients, counting cells in liposome images using a Transmission Electron Microscope led to high manpower requirement, high-cost consumption, and up to 35% manual error. We enabled it to reduce manual effort by up to 95% and increase accuracy by more than 90%.
We help pharmaceutical companies reduce their overall efforts by using computer vision solutions such as the automated cell counting software. The solution:
- Uses a Convoluted Neural Network (CNN) based Deep Learning counting model.
- Using it, we can detect and count the number of cells in a liposome image.
- Also, its interactive UI improves the interaction between humans and computers.
KOLs hold an influential place in the pharmaceutical landscape. But identifying them can be challenging due to the evolving landscape of pharmaceutical industry. Our KOL management solution takes care of that. It helps our clients uncover nuanced insights by:
- Leveraging Natural Language Processing (NLP) and variable associations.
- Delivering precise results by analyzing vast data and identifying patterns.
- Reducing rejections and elevating Net Promoter Score (NPS) metrics.
Pharma sales reps have the arduous task to not just sell but build relationships. Gramener’s personalized data & AI solutions suite will offer them:
- Tailor made communications strategy for physicians
- Custom incentives payout planning for sales teams
- Data-driven trade discount analytics for chemists
- Personalized prompts engine to guide sales reps
- Chemists network analytics to improve trade efficiency
Our Resources
The AI Chronicles #5: GPTs, EU CTIS, Med-PaLM2, and ClinicalGPT
OpenAI introduced GPTs, custom versions of ChatGPT designed for specific purposes. These versions, easily created without coding, will allow users to tailor ChatGPT to be more useful in their daily lives, work, or at home.
3 Mind-Blowing Insights from our Webinar on Generative AI in Pharma
The webinar stood out as a remarkable exception in a realm where webinars often teeter on the edge of monotony. Featuring Novartis, and Gramener this webinar explored the promising realm of generative AI in pharma.
The AI Chronicles #4: AWS HealthScribe, A Roche Report on Data Integration
In this blog post, we delve into the implications and significance of these latest tech advancements for the healthcare industry, and their resonance within the larger context of data-driven healthcare innovations.
What Our Clients Say
US Cold Storage is focused on better serving our customers and improving the supply chain. Through our partnership with Gramener, we’re succeeding on that journey
Mickey Hoffmann
SVP, Corporate Development US Cold StorageWe need to rapidly prototype AI applications for conservation, and it’s been fantastic to have Gramener on board as our Advanced Development Team.
Dan Morris
Principal Scientist and Program Director Microsoft AI for EarthGramener built a data marketplace which brought reports from multiple reporting platforms on to a single web interface. The experience working with Gramener was excellent.
Renee Hammitt
VP of Business Intelligence ConduentThe analytics-led innovations program in our R&D received a good fillip with contributions from Gramener team, primarily on unstructured data (Images & text extraction from documents).
Phani Mitra B
VP - Analytics & Strategy Dr. Reddy'sGramener’s expertise in providing effective ways to visualize complex data sets and processes is helping us make our products more interactive and more intuitive.
Nick Nikols
VP - Strategy Micro FocusThis project by Gramener is a good showcase of an AI-driven solution that addresses challenges faced by the Nisqually River Foundation.
Lucas Joppa
Chief Environmental Officer Microsoft AI for EarthGramener’s SlideSense product has allowed Scripps to produce PowerPoint deliverables for our Local Media division at scale, empowering us to shift analyst workloads to higher value activities across our portfolio of 61 local television stations in 41 markets.
Matt Booher
Director - Digital Insights The E.W. Scripps CompanyWe have been working with the Gramener team for the last few years across multiple program areas that we support in India. The deep expertise within Gramener, combined with their strong intent toward contributing to large-scale social impact programs, is what we respect the most.